Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis
- PMID: 33433365
- PMCID: PMC8018291
- DOI: 10.1016/j.semarthrit.2020.09.022
Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis
Abstract
Objective: To determine the incidence of dementia in patients with rheumatoid arthritis (RA) 65 years and older, and compare the incidence of dementia in patients with RA with prevalent cardiovascular (CV) disease (CVD), CV risk factors but no prevalent CVD and neither (referent group).
Methods: We analyzed claims data from the Center for Medicare & Medicaid Services (CMS) from 2006-2014. Eligibility criteria included continuous medical and pharmacy coverage for ≥ 12 months (baseline period 2006), > 2 RA diagnoses by a rheumatologist and at least 1 medication for RA. CVD and CV risk factors were identified using codes from the Chronic Condition Data Warehouse. Incident dementia was defined by 1 inpatient or 2 outpatient claims, or one dementia specific medication. Age-adjusted incident rates were calculated within each age strata. Univariate and multivariate Cox proportional hazard models were used to calculate Hazard Ratios (HR) and 95% confidence intervals.
Results: Among 56,567 patients with RA, 11,789 (20.1%) incident cases of dementia were included in the main analysis. Age adjusted incident rates were high among all groups and increased with age. After adjustment for age, sex, comorbidities and baseline CV and RA medications, patients with CVD and CV risk factors between 65 and 74 years had an increased risk for incident dementia compared to those without CVD and without CV risk factors (HR 1.18 (95% CI 1.04-1.33) and HR 1.03 (95% CI 1.00-1.11), respectively). We observed a trend towards increased risk in patients between 75 and 84 years with CVD at baseline.
Conclusion: Patients with RA with both CVD and CV risk factors alone are at an increased risk for dementia compared to those with neither CVD nor CV risk factors; however, this risk is attenuated with increasing age. The impact of RA treatment and CV primary prevention strategies in the prevention of dementia in patients with RA warrants further studies.
Keywords: Cardiovascular disease; Cardiovascular risk factors; Dementia; Rheumatoid arthritis.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest JRC received research support and consulting fees from AbbVie, Amgen, BMS, Corrona, Eli Lilly, Janssen, Myriad, Pfizer, Regeneron, Roche, UCB. SBL reports spousal ownership interests in Cigna, Intuitive Surgical, Inc., Merck, and Pfizer. INM received consulting fees from Sobi. SES, MR, GL, MS, and LAM declare no conflicts of interest.
Figures



Similar articles
-
Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study.J Rheumatol. 2023 Jan;50(1):48-55. doi: 10.3899/jrheum.220200. Epub 2022 Jul 15. J Rheumatol. 2023. PMID: 35840149 Free PMC article.
-
Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - Analysis of a national claims database.Semin Arthritis Rheum. 2022 Dec;57:152083. doi: 10.1016/j.semarthrit.2022.152083. Epub 2022 Aug 17. Semin Arthritis Rheum. 2022. PMID: 36155968
-
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.Rheumatol Int. 2024 Feb;44(2):291-301. doi: 10.1007/s00296-023-05515-y. Epub 2023 Dec 29. Rheumatol Int. 2024. PMID: 38157014
-
Prevention of cardiovascular disease in rheumatoid arthritis.Autoimmun Rev. 2015 Oct;14(10):952-69. doi: 10.1016/j.autrev.2015.06.004. Epub 2015 Jun 24. Autoimmun Rev. 2015. PMID: 26117596 Review.
-
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review.Autoimmun Rev. 2024 May;23(5):103539. doi: 10.1016/j.autrev.2024.103539. Epub 2024 Apr 4. Autoimmun Rev. 2024. PMID: 38582291
Cited by
-
Inflammation and aging-related disease: A transdisciplinary inflammaging framework.Geroscience. 2025 Feb;47(1):515-542. doi: 10.1007/s11357-024-01364-0. Epub 2024 Oct 1. Geroscience. 2025. PMID: 39352664 Free PMC article. Review.
-
Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities.Lancet Rheumatol. 2024 Dec;6(12):e871-e880. doi: 10.1016/S2665-9913(24)00190-5. Epub 2024 Nov 11. Lancet Rheumatol. 2024. PMID: 39542002 Free PMC article. Review.
-
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis.Semin Arthritis Rheum. 2024 Dec;69:152570. doi: 10.1016/j.semarthrit.2024.152570. Epub 2024 Oct 11. Semin Arthritis Rheum. 2024. PMID: 39413451
-
Habitual glucosamine use, APOE genotypes, and risk of incident cause-specific dementia in the older population.Alzheimers Res Ther. 2023 Sep 9;15(1):152. doi: 10.1186/s13195-023-01295-6. Alzheimers Res Ther. 2023. PMID: 37689747 Free PMC article.
-
Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study.J Rheumatol. 2023 Jan;50(1):48-55. doi: 10.3899/jrheum.220200. Epub 2022 Jul 15. J Rheumatol. 2023. PMID: 35840149 Free PMC article.
References
-
- Johnson NB, et al. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005–2013. MMWR supplements. 2014;63(4):3–27. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical